Diantha Duvall

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Diantha Duvall, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Diantha Duvall:

Company Role Class Num Shares Value Price $ Report Date Ownership
CURIS INC CFO Employee stock option (right to buy) 39,000 $453,180 $11.62 21 May 2024 Direct
CURIS INC CFO Employee stock option (right to buy) 135,000 $422,550 $3.13 20 May 2025 Direct
GENOCEA BIOSCIENCES, INC. CHIEF FINANCIAL OFFICER Common Stock 75,388 $94,235 $1.25 02 Jun 2022 Direct

Insider Reports Filed by Diantha Duvall

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRIS CURIS INC 20 May 2025 1 +$422,550 4 CFO 22 May 2025, 16:13
CRIS CURIS INC 28 Jan 2025 1 +$46,950 4 CFO 30 Jan 2025, 16:11
CRIS CURIS INC 21 May 2024 1 +$453,180 4 CFO 23 May 2024, 16:12
CRIS CURIS INC 20 Jan 2023 1 $0 4 CFO 24 Jan 2023, 15:10
CRIS CURIS INC 05 Aug 2022 0 $0 3 CFO 10 Aug 2022, 16:00
/report/000145761222000075-duvall-diantha-2022-06-02 GENOCEA BIOSCIENCES, INC. 02 Jun 2022 1 -$81.3 4 CHIEF FINANCIAL OFFICER 03 Jun 2022, 16:13
/report/000145761222000060-duvall-diantha-2022-05-26 GENOCEA BIOSCIENCES, INC. 26 May 2022 1 -$1,867 4 CHIEF FINANCIAL OFFICER 26 May 2022, 16:11
/report/000145761222000045-duvall-diantha-2022-04-04 GENOCEA BIOSCIENCES, INC. 04 Apr 2022 1 -$1,204 4 CHIEF FINANCIAL OFFICER 05 Apr 2022, 08:17
/report/000145761222000030-duvall-diantha-2022-03-15 GENOCEA BIOSCIENCES, INC. 15 Mar 2022 3 -$3,160 4 CHIEF FINANCIAL OFFICER 17 Mar 2022, 16:11
/report/000145761222000020-duvall-diantha-2021-12-31 GENOCEA BIOSCIENCES, INC. 31 Dec 2021 2 -$3,646 5 CHIEF FINANCIAL OFFICER 16 Mar 2022, 17:31